ABIO Financial Statements (ABIO)

Артген биотех (ИСКЧ)smart-lab.ru   2021 2022 2023 2024 2025   LTM ?
Report date 05.05.2022 29.04.2023 26.04.2024 28.04.2025 27.04.2026   27.04.2026
Currency RUB RUB RUB RUB RUB   RUB
Financial report URL  
Annual report URL  
Presentation URL  
Revenue, bln rub ? 1.18 1.14 1.37 1.52 1.72   1.72
Operating Income, bln rub 0.120 0.111 0.276 0.301 0.137   0.137
EBITDA, bln rub ? 0.155 0.164 0.347 0.322 0.215   0.215
Net profit, bln rub ? 0.012 0.046 0.169 0.215 0.097   0.097
OCF, bln rub ? 0.280 0.220 0.435 0.482 0.191   0.191
CAPEX, bln rub ? 0.153 0.218 0.204 0.100 0.170   0.170
FCF, bln rub ? 0.066 -0.042 0.191 0.185 -0.176   -0.176
Dividend payout, bln rub 0.085 0.111 0.092   0.092
Dividend, rub/share ? 1 1.2 1.2   1.2
Ordinary share dividend yield, % 0.0% 1.6% 1.2% 0.0% 1.8%   2.1%
Preferred share dividend, rub/share   0
Dividend payout ratio, % 0% 185% 66% 0% 95%   95%
OPEX, bln rub 1.06 1.03 1.09 1.22 1.58   1.58
Amortization, bln rub 0.1 0.1 0.1 0.1   0.1
R&D, bln rub 0.005 0.080 0.030 0.010 0.055  
Employment expenses, bln rub 0.253 0.245 0.258 0.281 0.332   0.332
Interest expenses, bln rub 0.051 0.049 0.052 0.077 0.072   0.072
Assets, bln rub 1.74 2.04 2.54 2.67 2.99   2.99
Net Assets, bln rub ? 0.234 0.341 0.424 0.368 0.474   0.474
Debt, bln rub 0.494 0.708 0.650 0.568 0.821   0.821
Cash, bln rub 0.193 0.202 0.544 0.503 0.565   0.565
Net debt, bln rub 0.30 0.51 0.11 0.07 0.26   0.26
Ordinary share price, rub 115.0 62.1 102.0 84.9 68.3   56.7
Number of ordinary shares, mln 85.0 92.6 92.6 92.6 92.6   92.6
Free Float, % 15.0% 21.7% 18.0%   18.0%
Market cap, bln rub 9.78 5.75 9.45 7.86 6.33   5.25
EV, bln rub ? 10.1 6.26 9.56 7.93 6.58   5.51
Book value, bln rub -0.31 -0.40 -0.38 -0.49 -0.41   -0.41
EPS, rub ? 0.14 0.50 1.82 2.32 1.05   1.05
FCF/share, rub 0.78 -0.45 2.06 2.00 -1.90   -1.90
BV/share, rub -3.64 -4.26 -4.06 -5.29 -4.39   -4.39
EBITDA margin, % ? 13.1% 14.4% 25.3% 21.2% 12.5%   12.5%
Net margin, % ? 1.0% 4.0% 12.3% 14.1% 5.7%   5.7%
FCF yield, % ? 0.7% -0.7% 2.0% 2.4% -2.8%   -3.4%
ROE, % ? 5.1% 13.5% 39.9% 58.4% 20.5%   20.5%
ROA, % ? 0.7% 2.3% 6.7% 8.0% 3.2%   3.2%
P/E ? 814.6 125.0 55.9 36.6 65.2   54.1
P/FCF 148.1 -136.9 49.5 42.5 -35.9   -29.8
P/S ? 8.28 5.06 6.90 5.17 3.69   3.06
P/BV ? -31.6 -14.6 -25.1 -16.0 -15.5   -12.9
EV/EBITDA ? 65.0 38.1 27.5 24.6 30.6   25.6
Debt/EBITDA 1.94 3.09 0.31 0.20 1.19   1.19
R&D/CAPEX, % 3.27% 36.70% 14.71% 10.00% 32.35%   0
CAPEX/Revenue, % 13% 19% 15% 7% 10%   10%
ABIO shareholders